Navigation Links
Lifeline Biotechnologies and Depository Trust Company
Date:9/30/2011

RENO, Nev., Sept. 30, 2011 /PRNewswire/ -- Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) announced today that the Company continues efforts to reestablish DTC services.

Jim Holmes, Lifeline's CEO said "While our efforts have continued to reestablish DTC's services to the Company we have not been successful.  We now are considering alternatives should the circumstances not change.

The value of Lifeline is not reflected in the current lack of liquidity (low per share market price and low daily volume of shares traded).  Lifeline's investment in First Warning Systems has not diminished; in fact, First Warning's value has appreciated as established milestones have been achieved.  Our focus in First Warning is preparation for the final round of clinical trials estimated to commence in the latter half of 2012.   At this time, our best estimate for trial completion is late 2013. The trails must be successfully completed before our FDA medical device marketing application is submitted in the U.S."

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, the ability to obtain financing, successful development of the Company's product or market acceptance of the product and regulatory and shareholder approval for anticipated actions.

CONTACT: Lifeline Biotechnologies, Inc.
Jim Holmes, 775-326-9614    Email: Jh
'/>"/>

SOURCE Lifeline Biotechnologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Solos Endoscopy, Inc. Sells Ovascope and Mastascope Product Line to Lifeline Biotechnologies, Inc.
2. Lifeline Skin Care™ Selects Click Here, Inc., Richards Partners
3. Epeius Biotechnologies Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal
4. Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program
5. Benjamin Custodio Joins Millennium Biotechnologies to Expand International Sales
6. Richter-Helm and Athera Biotechnologies Partner in Development of Recombinant Protein to Treat Cardiovascular Disease
7. Beginners Luck, or Creative Artists of the First Rank? Epeius Biotechnologies Launches Rexin-G eBook Tutorial
8. Commonwealth Biotechnologies Presents Data at Forensic Sciences Meeting Confirming Benefits of ZyGEMs DNA Extraction Technology
9. Andre Marion Joins Microchip Biotechnologies Board of Directors
10. TriLink BioTechnologies to Sponsor GIVING HUNGER THE BLUES, a Benefit Concert to Help Alleviate Hunger in San Diego County
11. TriLink BioTechnologies, Inc. Relaunches Oligonucleotide Radiolabeling Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... quickly produce ultra-lightweight, bendable batteries and supercapacitors in ... a sheet of paper with ink made of ... conductive storage device, said Yi Cui, assistant professor ... needs a low-cost, high-performance energy storage device, such ...
... 7 Vivakor, Inc. (OTC Bulletin Board: VIVK) today announced ... Chen and Fritz Lin, M.D. , Dr. Francis Chen ... as Board member of Vivakor, having held senior management positions ... Dr. Chen earned his Ph.D. in immunology from Harvard University, ...
... , VIENNA, Austria, December 7 ... for the,chemical industry, announced today that it has appointed Mr ... forward, EUCODIS Bioscience,sole focus will be to provide high-performance enzymes ... and,on its proven technology of "in vivo recombination". , ...
Cached Biology Technology:Dip ordinary paper into ink infused with nanotubes and nanowires to create an instant battery 2Vivakor Announces Additions to Board of Directors and Scientific Advisory Board 2Vivakor Announces Additions to Board of Directors and Scientific Advisory Board 3EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2
(Date:4/16/2014)... Armand-Frappier has just received a research grant from the ... nearly US$600,000. The 5-year grant is to pursue cutting-edge ... and to explore their biomedical potential in the field ... , "Receiving a grant at this level ... president of research and academic affairs at INRS. "It ...
(Date:4/16/2014)... array of finger-like projections called microvilli covers ... intestines., Vanderbilt University researchers have now discovered how ... critical for absorbing nutrients and defending against pathogens. ... Cell , reveal a role for adhesion ... understanding of intestinal pathologies associated with inherited and ...
(Date:4/16/2014)... memories improves during childhood, associated with structural changes ... and parietal cortices. New research from UC Davis ... this crucial time. Eventually, that could give insights ... into and during adolescence and affect memory, such ... the middle of the brain, the hippocampus plays ...
Breaking Biology News(10 mins):High-level NIH grant goes to professor Nicolas Doucet of INRS 2Vanderbilt researchers discover how intestinal cells build nutrient-absorbing surface 2Vanderbilt researchers discover how intestinal cells build nutrient-absorbing surface 3How kids' brain structures grow as memory develops 2
... To arrange for an interview with a researcher, please contact ... of each tip. For more information on ORNL and its research ... If you have a general media-related question or comment, you can ... -- Battling bugs . . . The software-writing ...
... have discovered a novel mechanism in Salmonella that ... its production of proteins in a previously unheard of manner. ... of certain proteins to respond to inhospitable conditions. ... were intrigued to find evidence of a similar mechanism in ...
... 29, 2010): Today, the Association for Molecular Pathology (AMP) submitted ... by the National Institutes of Health (NIH) for its Genetic ... membership to formulate a comprehensive response to the RFI. ... laboratory setting, AMP is able to inform the NIH on ...
Cached Biology News:Story tips from the Department of Energy's Oak Ridge National Laboratory, August 2010 2Story tips from the Department of Energy's Oak Ridge National Laboratory, August 2010 3Story tips from the Department of Energy's Oak Ridge National Laboratory, August 2010 4Mechanism uncovered behind Salmonella virulence and drug susceptibility 2Mechanism uncovered behind Salmonella virulence and drug susceptibility 3Mechanism uncovered behind Salmonella virulence and drug susceptibility 4AMP responds to Genetic Test Registry request for information 2
... new product number, created to easily match ... yet, please order under the old Sigma-Aldrich ... assistance. ID clarifier: tissue-culture treated ... cm 2 D H 245 ...
BD BioCoat Collagen IV 150 mm Culture Dishes...
...
...
Biology Products: